Publication:
Bacteria-instructed B cells cross-prime naïve CD8+ T cells triggering effective cytotoxic responses.

dc.contributor.authorGarcía-Ferreras, Raquel
dc.contributor.authorOsuna-Pérez, Jesús
dc.contributor.authorRamírez-Santiago, Guillermo
dc.contributor.authorMéndez-Pérez, Almudena
dc.contributor.authorAcosta-Moreno, Andrés M
dc.contributor.authorDel Campo, Lara
dc.contributor.authorGómez-Sánchez, María J
dc.contributor.authorIborra, Marta
dc.contributor.authorHerrero-Fernández, Beatriz
dc.contributor.authorGonzález-Granado, José M
dc.contributor.authorSánchez-Madrid, Francisco
dc.contributor.authorCarrasco, Yolanda R
dc.contributor.authorBoya, Patricia
dc.contributor.authorMartínez-Martín, Nuria
dc.contributor.authorVeiga, Esteban
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderMinisterio de Economía, Innovación y Competitividad (España)es_ES
dc.contributor.funderFundación La Caixaes_ES
dc.date.accessioned2023-09-07T13:16:47Z
dc.date.available2023-09-07T13:16:47Z
dc.date.issued2023-07-05
dc.description.abstractIn addition to triggering humoral responses, conventional B cells have been described in vitro to cross-present exogenous antigens activating naïve CD8+ T cells. Nevertheless, the way B cells capture these exogenous antigens and the physiological roles of B cell-mediated cross-presentation remain poorly explored. Here, we show that B cells capture bacteria by trans-phagocytosis from previously infected dendritic cells (DC) when they are in close contact. Bacterial encounter "instructs" the B cells to acquire antigen cross-presentation abilities, in a process that involves autophagy. Bacteria-instructed B cells, henceforth referred to as BacB cells, rapidly degrade phagocytosed bacteria, process bacterial antigens and cross-prime naïve CD8+ T cells which differentiate into specific cytotoxic cells that efficiently control bacterial infections. Moreover, a proof-of-concept experiment shows that BacB cells that have captured bacteria expressing tumor antigens could be useful as novel cellular immunotherapies against cancer.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe are grateful to advanced light microscopy and cytometry facilities of CNB for technical supporting. The research is supported by grants: SAF2017-84091- R, and PID2020-116393RB-I00/AEI/10.13039/501100011033, financed by MCIN, BFERO2020.04, financed by FERO foundation and PI20/0036 from ISCIII. RGF is supported by BES-2016-076526 from the Spanish Ministry of Economy Industry and Competitiveness, JOP is supported by fellowship LCF/BQ/SO16/ 52270012 from La Caixa, BHF is supported by FPU18/00895 and AMP by FPU18/03199 from Ministry of Science, Innovation and Universities. LdC has been supported by Juan de la Cierva grant IJC2018-035386-I and a contract associated to SEV-2017-0712. EVC, AMP, AMAM, and NMM belong to the Spanish National Research Council (CSIC)’s Cancer Hub. Synopsis image made with biorender.com by Eduardo Roman Camacho and Esteban Veiga. We thanks Prof. Dan Portnoy who kindly provided bacterial strains.es_ES
dc.format.number7es_ES
dc.format.pagee56131es_ES
dc.format.volume24es_ES
dc.identifier.citationEMBO Rep. 2023 Jul 5;24(7):e56131es_ES
dc.identifier.doi10.15252/embr.202256131es_ES
dc.identifier.e-issn1469-3178es_ES
dc.identifier.journalEMBO reportses_ES
dc.identifier.pubmedID37184882es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16425
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2017-84091-Res_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2020-116393RB-I00/AEI/10.13039/501100011033es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/BFERO2020.04es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI20/0036es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/BES-2016-076526es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/BQ/SO16/52270012es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU18/00895es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU18/03199es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJC2018-035386-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SEV-2017-0712es_ES
dc.relation.publisherversion10.15252/embr.202256131es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Comunicación Intercelular en la Respuesta Inflamatoriaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshCD8-Positive T-Lymphocyteses_ES
dc.subject.meshDendritic Cellses_ES
dc.subject.meshAntigen Presentationes_ES
dc.subject.meshCross-Priminges_ES
dc.subject.meshAntigens, Bacteriales_ES
dc.titleBacteria-instructed B cells cross-prime naïve CD8+ T cells triggering effective cytotoxic responses.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bacteria-instructed B cells_EMBO Rep_2023.pdf
Size:
2.06 MB
Format:
Adobe Portable Document Format
Description:
Artículo